Thromboprophylaxis with dabigatran etexilate in patients over seventy-five years of age with moderate renal impairment undergoing or knee replacement

Eitemau Tebyg

• Erratum to: Thromboprophylaxis in patients older than 75 years or with moderate renal impairment undergoing knee or hip replacement surgery
  gan: Dahl, Ola E., et al.
  Cyhoeddwyd: (2012)
• Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized controlled trials
  gan: Rosencher Nadia, et al.
  Cyhoeddwyd: (2012-06-01)
• Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized controlled trials
  gan: Rosencher, Nadia, et al.
  Cyhoeddwyd: (2012)
• Dabigatran etexilate for thromboprophylaxis in over 5000 hip or knee replacement patients in a real-world clinical setting
  gan: Rosencher, Nadia, et al.
  Cyhoeddwyd: (2016)
• Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty: pooled analysis of two phase 3 randomized trials
  gan: Eriksson, Bengt I., et al.
  Cyhoeddwyd: (2015)